journal article·2021-08

Synthetic nanostructured wollastonite: Composition, structure and “in vitro” biocompatibility investigation

E.K. Papynov, O.O. Shichalin, V.I. Apanasevich, N.G. Plekhova, I. Yu Buravlev, S.V. Zinoviev, V. Yu Mayorov, A.N. Fedorets, E.B. Merkulov, D. Kh Shlyk, V.A. Nepomnyushchaya, Z.E. Kornakova, I.S. Afonin, I.O. Evdokimov, O.V. Korshunova

Ceramics International· Volume 47· Issue 16
Publisher page

Abstract

Abstract This article describes an original sol-gel (template) method for the synthesis of a dispersed form of nanostructured wollastonite (CaSiO3), its gold nanoparticles (40–60 nm) functionalized form CaSiO3/Au-NPs, and its composite in the composition with 20 mass% of hydroxyapatite CaSiO3/HAp and synthetic hydroxyapatite, that are widely used in medicine for the reconstruction and regeneration of bone defects. The method provides the formation of porous silica carcass in samples with an average pore size of 100–160 nm due to the application of polymer siloxane-acrylate as a pore-forming template. The authors studied the processes of template destruction and phase formation in the composition of samples using TGA/DTA/DSC (thermogravimetric analysis/differential thermal analysis/differential scanning calorimetry), and XRD (X-ray diffraction analysis). The methods of SEM (scanning electron microscopy), low-temperature nitrogen adsorption, and mercury porosimetry were used to identify the morphology and study the structural characteristics (Sspec and Vpor, pore size distribution) for dispersed nanostructured samples based on wollastonite and hydroxyapatite. An “in vitro” model was used to study the functional activity (metabolism and cytokine production) of innate immune cells (neutrophils and macrophages) in contact with the obtained samples and to evaluate the viability of cells, the activity of ATPase activity, the number of cationic proteins, and apoptosis of cells. The study is novel for these systems and contributes to the existing knowledge on the biocompatibility for “in vivo” model, which provides a complex evaluation of the quality of wollastonite biomaterials used as grafts.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Bioactive ceramic composite material stability, characterization, and bonding to bone10.1016/B978-0-08-102203-0.00012-3 ↗
2. Scaffolds containing chitosan/carboxymethyl cellulose/mesoporous wollastonite for bone tissue engineering10.1016/j.ijbiomac.2015.07.016 ↗
3. Processing and characterization of poly (butylene adipate-co-terephthalate)/Wollastonite biocomposites for medical applications10.1016/j.matpr.2017.11.279 ↗
4. In vitro bioactivity and degradation behaviour of β-wollastonite derived from natural waste10.1016/j.msec.2018.12.101 ↗
5. Bioactivity of wollastonite ceramics: in vitro evaluation10.1016/0956-716X(94)90517-7 ↗
6. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics10.1177/0885328208094745 ↗
7. Synthesis and in vivo evaluation of a scaffold containing wollastonite/β‐TCP for bone repair in a rabbit tibial defect model
8. The role of silicon in osteoblast-like cell proliferation and apoptosis10.1016/j.actbio.2011.02.023 ↗
9. Osteogenic differentiation of osteoblasts induced by calcium silicate and calcium silicate/β-tricalcium phosphate composite bioceramics10.1002/jbm.b.32688 ↗
10. Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration10.1016/j.actbio.2017.08.044 ↗
11. Phase pure, high hardness, biocompatible calcium silicates with excellent anti-bacterial and biofilm inhibition efficacies for endodontic and orthopaedic applications10.1016/j.jmbbm.2018.06.046 ↗
12. Wollastonite toxicity: an update10.3109/08958378.2013.857372 ↗
13. Peppas · 1998
14. Ravaglioli · 1992
15. In vitro behaviour of sol-gel interconnected porous scaffolds of doped wollastonite10.1016/j.ceramint.2017.05.146 ↗
16. A simple method to synthesize single-crystalline β-wollastonite nanowires10.1016/j.jcrysgro.2006.11.215 ↗
17. Hydrothermal synthesis of β-dicalcium silicate (β-Ca2SiO4)10.1016/j.pcrysgrow.2006.03.011 ↗
18. Mechanical and physical properties of calcium silicate/alumina composite for biomedical engineering applications10.1016/j.jmbbm.2013.10.024 ↗
19. Osteoinduction of 3D printed particulate and short-fibre reinforced composites produced using PLLA and apatite-wollastonite10.1016/j.compscitech.2019.107834 ↗
20. Selective laser sintered bio-inspired silicon-wollastonite scaffolds for bone tissue engineering10.1016/j.msec.2020.111223 ↗
21. Application of carbonaceous template for porous structure control of ceramic composites based on synthetic wollastonite obtained via Spark Plasma Sintering10.1016/j.ceramint.2014.09.045 ↗
22. Reactive spark plasma synthesis of porous bioceramic wollastonite10.1134/S0036023620020138 ↗
23. Sol-gel and SPS combined synthesis of highly porous wollastonite ceramic materials with immobilized Au-NPs10.1016/j.ceramint.2017.03.207 ↗
24. Wollastonite ceramics with bimodal porous structures prepared by sol-gel and SPS techniques10.1039/C6RA04956G ↗
25. Sol-gel (template) synthesis of osteoplastic CaSiO3/HAp powder biocomposite: “In vitro” and “in vivo” biocompatibility assessment10.1016/j.powtec.2020.04.040 ↗
26. Synthetic CaSiO3 sol-gel powder and SPS ceramic derivatives: “In vivo” toxicity assessment10.1016/j.pnsc.2019.07.004 ↗
27. Morphological characteristics of the osteoplastic potential of synthetic CaSiO3/HAp powder biocomposite10.3390/jfb11040068 ↗
28. Coping with antibiotic resistance : combining nanoparticles with antibiotics and other antimicrobial agents10.1586/eri.11.121 ↗
29. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver , zinc oxide , and gold10.1016/j.nano.2008.04.005 ↗
30. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci10.3109/10717544.2012.746402 ↗
31. Nanomaterials as antimicrobial agents
32. Antifungal activity of gold nanoparticles prepared by solvothermal method10.1016/j.materresbull.2012.09.069 ↗
33. Colloids and Surfaces B : biointerfaces Size and shape dependant antifungal activity of gold nanoparticles : a case study of Candida10.1016/j.colsurfb.2012.06.005 ↗
34. Gold nanoparticles downregulate interleukin-1 β - induced pro-infl ammatory responses10.1002/smll.201201528 ↗
35. Influences of size and surface coating of gold nanoparticles on inflammatory activation of macrophages10.1016/j.colsurfb.2017.09.046 ↗
36. Biomimetic synthesis of metal – hydroxyapatite ( Au-HAp , Ag-HAp , Au-Ag-HAp ): structural analysis , spectroscopic characterization and biomedical application10.1016/j.ceramint.2018.08.045 ↗
37. International Journal of Biological Macromolecules Nanocomposite chitosan fi lm containing graphene oxide/hydroxyapatite/gold for bone tissue engineering10.1016/j.ijbiomac.2020.03.095 ↗
38. Preparation of gold/hydroxyapatite hybrids using natural fish scale template and their effective albumin interactions
39. Gold dotted hydroxyapatite nanoparticles as multifunctional platforms for medical applications10.1039/C5RA11978B ↗
40. Liang · 2019
41. Neutrophils in tissue trauma of the skin, bone, and lung: two sides of the same coin10.1155/2018/8173983 ↗
42. Mechanisms underlying neutrophil-mediated monocyte recruitment10.1182/blood-2009-06-221630 ↗
43. Application of natural neutrophil products for stimulation of monocyte-derived macrophages obtained before and after osteochondral or bone injury10.3390/microorganisms9010124 ↗
44. Macrophage phenotypes and their modulation in atherosclerosis10.1253/circj.CJ-14-0621 ↗
45. Interactions between MSCs and immune cells: implications for bone healing10.1155/2015/752510 ↗
46. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation10.3389/fimmu.2014.00514 ↗
47. Sol–gel synthesis of porous inorganic materials using “core–shell” latex particles as templates10.1007/s10971-013-3039-0 ↗
48. Peculiarities of formation of phase composition, porous structure, and catalytic properties of tungsten oxide-based macroporous materials fabricated by sol-gel synthesis10.1016/j.matchar.2013.12.003 ↗
49. Synthesis, morphology and rheology of core-shell silicone acrylic emulsion stabilized with polymerisable surfactant10.3144/expresspolymlett.2010.82 ↗
50. Kinetics and mechanism of the oxidation of oxalic acid by tetrachloroaurate(III) ion10.1016/j.ica.2007.03.006 ↗
51. Sugawara · 2007
52. Synthesis of calcium phosphate and calcium silicate composites10.1134/S0036023618080211 ↗
53. Thermal behaviour of hydroxyapatite intended for medical applications10.1016/0142-9612(93)90146-S ↗
54. Phase transformation on hydroxyapatite decomposition10.1016/j.ceramint.2012.10.221 ↗
55. Mechanical and bioactive behavior of hydroxyapatite – wollastonite sintered composites10.1111/j.1744-7402.2009.02377.x ↗
56. Fabrication and characterization of hydroxyapatite/wollastonite composite bioceramics with controllable properties for hard tissue repair10.1111/j.1551-2916.2010.04046.x ↗
57. New type of bioactive materials : hydroxyapatite/alpha-wollastonite composites10.1557/JMR.2005.0144 ↗
58. An overview of cell death mechanisms in eukaryotes10.1007/s10565-019-09496-2 ↗
59. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib10.1016/j.semcancer.2019.10.013 ↗